Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.

Konya H, Hasegawa Y, Hamaguchi T, Satani K, Umehara A, Katsuno T, Ishikawa T, Miuchi M, Kohri K, Suehiro A, Kakishita E, Miyagawa J, Namba M.

Metabolism. 2010 Sep;59(9):1294-9. doi: 10.1016/j.metabol.2009.12.004. Epub 2010 Jan 12.

PMID:
20070990
2.

Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.

Satani K, Konya H, Hamaguchi T, Umehara A, Katsuno T, Ishikawa T, Kohri K, Hasegawa Y, Suehiro A, Kakishita E, Namba M.

Diabet Med. 2006 Jun;23(6):617-22.

PMID:
16759302
3.

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.

Tsunemi S, Iwasaki T, Imado T, Higasa S, Kakishita E, Shirasaka T, Sano H.

AIDS. 2005 Jun 10;19(9):879-86.

PMID:
15905668
4.

Involvement of interleukin-18 in acute graft-versus-host disease in mice.

Itoi H, Fujimori Y, Tsutsui H, Matsui K, Sugihara A, Terada N, Hada T, Kakishita E, Okamura H, Hara H, Nakanishi K.

Transplantation. 2004 Nov 15;78(9):1245-50.

PMID:
15548959
5.

Age related elevation of serum macrophage colony stimulating factor (M-CSF) level.

Suehiro A, Imagawa T, Hosokawa H, Suehiro M, Ohe Y, Kakishita E.

Arch Gerontol Geriatr. 1999 Jul-Aug;29(1):13-20.

PMID:
15374073
6.

Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation.

Takatsuka H, Wakae T, Toda A, Itoi H, Okada M, Misawa M, Hara H, Kakishita E.

Clin Transplant. 2004 Oct;18(5):547-51.

PMID:
15344958
7.

Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.

Itoi H, Fujimori Y, Tsutsui H, Matsui K, Hada T, Kakishita E, Okamura H, Hara H, Nakanishi K.

J Interferon Cytokine Res. 2004 May;24(5):291-6.

PMID:
15153312
8.

Idiopathic interstitial pneumonia following stem cell transplantation.

Yamaguchi N, Takatsuka H, Wakae T, Okada M, Fujimori Y, Okamoto T, Kakishita E, Hara H.

Clin Transplant. 2003 Aug;17(4):338-46.

PMID:
12868990
9.

Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.

Wakae T, Takatsuka H, Seto Y, Iwata N, Mori A, Okada M, Fujimori Y, Okamoto T, Kakishita E, Hara H.

Hematology. 2002 Oct;7(5):305-10.

PMID:
12850818
10.

Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.

Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Okamoto T, Kakishita E, Hara H.

Bone Marrow Transplant. 2003 May;31(10):905-8.

PMID:
12748667
11.

Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease.

Ogata A, Kitano M, Yamanaka J, Yamasaki T, Hashimoto N, Iwasaki T, Hamano T, Fujimoto J, Kakishita E.

J Rheumatol. 2003 May;30(5):1093-6.

PMID:
12734913
12.

Influence of Helicobacter pylori on platelets after bone marrow transplantation from unrelated donors.

Wakae T, Takatsuka H, Mori A, Okada M, Fujimori Y, Okamoto T, Hara H, Kakishita E.

Bone Marrow Transplant. 2003 Mar;31(6):493-6.

PMID:
12665846
13.

Endothelial damage caused by cytomegalovirus and human herpesvirus-6.

Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E.

Bone Marrow Transplant. 2003 Mar;31(6):475-9.

PMID:
12665843
14.

Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus.

Hasegawa Y, Suehiro A, Higasa S, Namba M, Kakishita E.

Thromb Res. 2002 Sep 15;107(6):319-23.

PMID:
12565718
15.

Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation.

Takatsuka H, Takemoto Y, Yamada S, Wakae T, Mori A, Okada M, Iwata N, Okamoto T, Kanamaru A, Kakishita E.

Drugs Exp Clin Res. 2002;28(4):121-5.

PMID:
12512229
16.

Intestinal graft-versus-host disease: mechanisms and management.

Takatsuka H, Iwasaki T, Okamoto T, Kakishita E.

Drugs. 2003;63(1):1-15. Review.

PMID:
12487619
17.

Effect of eicosapentaenoic acid in patients with refractory myelodysplastic syndrome.

Okamoto T, Okada M, Wakae T, Takatsuka H, Kakishita E.

Am J Hematol. 2002 Dec;71(4):350-1. No abstract available.

18.

Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report.

Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Sugihara A, Terada N, Kanamaru A, Kakishita E.

Hematology. 2002 Jun;7(3):169-72.

PMID:
12243980
19.

Effects of total body irradiation on the vascular endothelium.

Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E.

Clin Transplant. 2002 Oct;16(5):374-7.

PMID:
12225435
20.

Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.

Fujimori Y, Yoshimoto T, Matsui K, Tsutsui H, Okamoto T, Kashiwamura S, Hada T, Okamura H, Kakishita E, Hara H, Nakanishi K.

J Interferon Cytokine Res. 2002 Jul;22(7):751-4.

PMID:
12184912
21.

Intracellular alkalinization augments platelet aggregation due to increase in cytosolic free-Ca2+.

Marumo M, Suehiro A, Kakishita E, Wakabayashi I.

Platelets. 2002 May;13(3):159-65.

PMID:
12180498
22.

Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.

Takatsuka H, Takemoto Y, Yamada S, Mori A, Wada H, Fujimori Y, Okamoto T, Kanamaru A, Kakishita E.

Hematology. 2002 Feb;7(1):55-7.

PMID:
12171778
23.

Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease.

Ogata A, Kitano M, Hashimoto N, Iwasaki T, Hamano T, Kakishita E.

J Bone Miner Metab. 2002;20(4):240-2. No abstract available.

PMID:
12115071
24.

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.

Takatsuka H, Wakae T, Mori A, Okada M, Suehiro A, Okamoto T, Kakishita E.

Bone Marrow Transplant. 2002 Jun;29(11):907-11.

25.

[Pneumonitis with a bronchiolitis obliterans organizing pneumonia-like shadow in a patient with human herpes virus-6 viremia after allogeneic bone marrow transplantation].

Yata K, Nakajima M, Takemoto Y, Yamada O, Okada M, Takatsuka H, Okamoto T, Wada H, Otsuki T, Yawata Y, Kakishita E, Sugihara T.

Kansenshogaku Zasshi. 2002 May;76(5):385-90. Japanese.

PMID:
12073575
26.

The molecular mechanism in activation-induced cell death of an Ag-reactive B cell clone.

Hamano T, Iwasaki T, Ogata A, Hashimoto N, Kakishita E.

Clin Exp Immunol. 2002 Jun;128(3):436-43.

27.

Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor.

Takatsuka H, Takemoto Y, Mori A, Okamoto T, Kanamaru A, Kakishita E.

Chest. 2002 May;121(5):1716-20.

PMID:
12006472
28.

Expression of the antiapoptosis gene survivin in human leukemia.

Mori A, Wada H, Nishimura Y, Okamoto T, Takemoto Y, Kakishita E.

Int J Hematol. 2002 Feb;75(2):161-5.

PMID:
11939262
29.

Suitability of four polymorphic DNA markers for indirect genetic diagnosis of haemophilia A in Japanese subject.

Sawada A, Sumita C, Higasa S, Ueda M, Suehiro A, Kakishita E.

Thromb Res. 2002 Feb 1;105(3):271-6.

PMID:
11927134
30.

Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.

Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kitano M, Kakishita E.

Br J Haematol. 2002 Mar;116(4):796-802.

PMID:
11886383
31.

Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.

Suehiro A, Sawada A, Hasegawa Y, Takatsuka H, Higasa S, Kakishita E.

Bone Marrow Transplant. 2002 Jan;29(2):107-11.

32.

Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.

Okamoto T, Okada M, Wakae T, Mori A, Takatsuka H, Kakishita E.

Int J Hematol. 2002 Jan;75(1):107-8. No abstract available.

PMID:
11843282
33.

Oral eicosapentaenoic acid for complications of bone marrow transplantation.

Takatsuka H, Takemoto Y, Iwata N, Suehiro A, Hamano T, Okamoto T, Kanamaru A, Kakishita E.

Bone Marrow Transplant. 2001 Oct;28(8):769-74.

34.

Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration.

Iwasaki T, Nakata A, Mukai M, Shinkai K, Yano H, Sabe H, Schaefer E, Tatsuta M, Tsujimura T, Terada N, Kakishita E, Akedo H.

Int J Cancer. 2002 Jan 20;97(3):330-5.

35.

Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry.

Marumo M, Suehiro A, Kakishita E, Groschner K, Wakabayashi I.

Thromb Res. 2001 Dec 1;104(5):353-60.

PMID:
11738078
36.

Treatment of intestinal graft-versus-host disease using betamethasone enemas.

Wada H, Mori A, Okada M, Takatsuka H, Tamura A, Seto Y, Iwata N, Fujimori Y, Okamoto T, Takemoto Y, Kakishita E.

Transplantation. 2001 Oct 27;72(8):1451-3.

PMID:
11685119
37.

Daunorubicin inhibits gene expression of cyclooxygenase-2 in vascular smooth muscle cells.

Yasui K, Wakabayashi I, Negoro M, Suehiro A, Kakishita E.

Thromb Res. 2001 Aug 1;103(3):233-40.

PMID:
11672585
38.

Relationship between immunological abnormalities and paroxysmal nocturnal haemoglobinuria-associated clones in myelodysplastic syndromes.

Okamoto T, Okada M, Takatsuka H, Wada H, Fujimori Y, Kakishita E.

Br J Haematol. 2001 Sep;114(3):731-3. No abstract available.

PMID:
11553007
39.

Increased hepatocyte growth factor in serum in acute graft-versus-host disease.

Okamoto T, Takatsuka H, Fujimori Y, Wada H, Iwasaki T, Kakishita E.

Bone Marrow Transplant. 2001 Jul;28(2):197-200.

40.

The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.

Kataoka Y, Iwasaki T, Kuroiwa T, Seto Y, Iwata N, Hashimoto N, Ogata A, Hamano T, Kakishita E.

Immunology. 2001 Jul;103(3):310-8.

41.

Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease.

Itoi H, Fujimori Y, Tsutsui H, Matsui K, Futatsugi S, Okamura H, Hara H, Hada T, Kakishita E, Nakanishi K.

Blood. 2001 Jul 1;98(1):235-7.

PMID:
11418486
42.

Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function.

Kuroiwa T, Kakishita E, Hamano T, Kataoka Y, Seto Y, Iwata N, Kaneda Y, Matsumoto K, Nakamura T, Ueki T, Fujimoto J, Iwasaki T.

J Clin Invest. 2001 Jun;107(11):1365-73.

43.

Urinary trypsin inhibitor concentration can predict the immunological insult of chemotherapy and complications after bone marrow transplantation.

Yamada S, Takatsuka H, Takemoto Y, Wada H, Fujimori Y, Okamoto T, Kanamaru A, Kakishita E.

Bone Marrow Transplant. 2001 Jan;27(2):195-9.

44.

Increased expression of Fas (APO-1, CD95) on CD4+ and CD8+ T lymphocytes during total body irradiation.

Fujimori Y, Saheki K, Itoi H, Okamamoto T, Kakishita E.

Acta Haematol. 2000;104(4):193-6.

PMID:
11279310
45.

Predicting the severity of intestinal graft-versus-host disease from leukotriene B4 levels after bone marrow transplantation.

Takatsuka H, Yamada S, Okamoto T, Fujimori Y, Wada H, Iwata N, Kanamaru A, Kakishita E.

Bone Marrow Transplant. 2000 Dec;26(12):1313-6.

46.

Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.

Okamoto T, Nishimura Y, Yamada S, Yamada S, Itoh T, Mori A, Saheki K, Okada M, Takatsuka H, Wada H, Tamura A, Fujimori Y, Kakishita E.

Acta Haematol. 2000;104(2-3):128-30.

PMID:
11154989
47.

Similarity Between Multiple Sclerosis and Idiopathic Central Nervous System Dysfunction After Bone Marrow Transplantation.

Yamada S, Takatsuka H, Takemoto Y, Mori A, Wada H, Fujimori Y, Okamoto T, Kanamaru A, Kakishita E.

Hematology. 2001;6(2):125-9. doi: 10.1080/10245332.2001.11746562.

PMID:
27419878
48.

Herpesvirus Infection in Patients Following Bone Marrow Transplantation: Influence of Viral Reactivation on Prognosis.

Takatsuka H, Takemoto Y, Yamada S, Mori A, Okada M, Wada H, Fujimori Y, Okamoto T, Kanamaru A, Kakishita E.

Hematology. 2001;5(6):441-5. doi: 10.1080/10245332.2001.11746541.

PMID:
27419347
49.

Acute Colonic Graft-versus-host Disease and Ulcerative Colitis with Respect to Cytokines.

Yamada S, Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Wada H, Iwata N, Seto Y, Kanamaru A, Kakishita E.

Hematology. 2001;6(5):315-20. doi: 10.1080/10245332.2001.11746585.

PMID:
27405525
50.

Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies.

Tamura S, Saheki K, Takatsuka H, Wada H, Fujimori Y, Okamoto T, Takemoto Y, Hashimoto-Tamaoki T, Furuyama J, Kakishita E.

Ann Hematol. 2000 Nov;79(11):622-6.

PMID:
11131921

Supplemental Content

Loading ...
Support Center